Funds & Fund Managers
The equity sectors seeing the biggest H1 2017 inflows
A deep-dive into the sectors bagging the most money and the managers leading the pack.
Now's a bad time to buy biotech...says Pictet biotech manager
Sector specialist says major market events could prove problematic.
Ten fund buyers name their favourite veteran managers
Which of the industry's older statesmen are selectors trusting to outperform for years to come.
ClearBridge’s Bauman calms clients despite contrarian stance
Equity veteran defends underperformance of his US Aggressive Growth fund.